Protein kinase C delta (PKCd) is a serine (Ser)/threonine kinase, which regulates numerous cellular processes, including proliferation, differentiation, migration and apoptosis. In the current study, Chinese hamster ovary cells were transfected with either a constitutively activated PKCd or a dominant negative PKCd, phosphoprotein enrichment, two-dimensional difference gel electrophoresis and mass spectrometry was combined to globally identified candidates of PKCd cascade. We found that Bcl-2 associated athanogene 3 (BAG3) was one of the targets of PKCd cascade, and BAG3 interacted with PKCd in vivo. In addition, we clarified that BAG3 was phosphorylate at Ser187 site in a PKCd-dependent manner in vivo. BAG3 has been implicated in multiple cellular functions, including proliferation, differentiation, apoptosis, migration, invasion, macroautophagy and so on. We generated wild-type (WT)-, Ser187Ala (S187A)-or Ser187Asp (S187D)-BAG3 stably expressing FRO cells, and noticed that phosphorylation state of BAG3 influenced FRO morphology. Finally, for the first time, we showed that BAG3 was implicated in epithelial À mesenchymal transition (EMT) procedure, and phosphorylation state at Ser187 site had a critical role in EMT regulation by BAG3. Collectively, the current study indicates that BAG3 is a novel substrate of PKCd, and PKCd-mediated phosphorylation of BAG3 is implicated in EMT and invasiveness of thyroid cancer cells.
INTRODUCTION
The protein kinase C (PKC) family of serine (Ser)/threonine kinases comprises at least 12 isoforms, which are classified into three categories based on differential Ca 2 þ and lipid requirements for activation. The classical PKCs (a, b1, b2 and g) require both Ca 2 þ and either diacylglycerol or phorbol esters for full activation. The novel PKCs (e, d, Z, y, m and n) are diacylglycerol sensitive but Ca 2 þ unresponsive, whereas the atypical PKCs (z and l) are insensitive to both Ca 2 þ and diacylglycerol. 1 PKC isoforms control a large number of cellular functions through specific phosphorylation of intracellular substrates. PKC delta (PKCd), a novel PKC, is ubiquitously expressed and has been implicated in a wide variety of cellular functions, most prominently, has a critical role in the control of cell proliferation, differentiation, apoptosis, migration and cytoskeleton remodeling. [2] [3] [4] [5] [6] [7] In light of the wide physiological significance of PKCd, we used three key methodologies, enrichment of phosphorylated proteins, fluorescent two-dimensional (2D) difference gel electrophoresis (2D-DIGE) and mass spectrometric identification of proteins, to globally identify the factors involved in the PKCd cascades. We identified that Bcl-2 associated athanogene 3 (BAG3) was one of the candidates for targets of PKCd-dependent phosphorylation in vivo. In addition, we identified that PKCd phosphorylated BAG3 on Ser187 site.
BAG3 has been identified as a Bcl-2 associated protein in protein interaction techniques. [8] [9] [10] BAG3 expression has been found to be increased in several tumors, including thyroid, leukemia, pancreatic and ovarian tumors. [11] [12] [13] [14] [15] [16] Downregulation of BAG3 sensitizes tumor cells to apoptotic cell death induced by several anti-cancer drugs, 11, 13, 14, [16] [17] [18] [19] suggesting the prosurvival function of BAG3. Furthermore, it has been reported that BAG3 regulates adhesion and migration of invasion of tumor cells, thereby contributes to tumorigenesis and metastasis of malignant tumors in vivo. 16, 20, 21 Epithelial-mesenchymal transition (EMT) is an orchestrated series of transcriptional and morphological program, in which expression of epithelial genes is suppressed and expression of mesenchymal genes is activated. Downregulated genes include those encoding proteins, maintaining epithelial cell-cell adhesions, such as E-cadherin, claudins and occludin. Upregulated genes include those encoding proteins promoting cell migration and invasion, such as N-cadherin, vimentin, fibronectin and collagen. EMT is achieved when epithelial cells lose intracellular junctions and acquire mesenchymal-like characteristics. During EMT procedure, the actin À cytoskeleton is reorganized, and cells acquire increased cell-matrix contacts, causing dissociation from surrounding cells and enhanced migratory and invasive capabilities. 22 This important process was initially recognized during embryonic development, and has more recently been implicated in progression of primary tumors toward metastases.
Thyroid cancer is the most common neoplasm of the endocrine system. The incidence of this disease has been rising steadily during past decades. 24 The prognosis of thyroid cancer correlates highly with invasive status. 24 Therefore, understanding mechanisms of thyroid cancer invasion may facilitate the advancement of clinical treatment. In the current study, we constructed wild-type (WT) BAG3 (WT-BAG3), Ser187 nonphosphorylatable BAG3 mutant (S187A-BAG3) and Ser187 phosphomimetic BAG3 mutant (S187D-BAG3) eukaryotic expression vectors, and generated thyroid cancer FRO cells stably expressing WT-BAG3, S187A-BAG3 or S187D-BAG3 to investigate the function of PKCd-mediated phosphorylation of BAG3 at Ser187 site. We noticed different morphologies of these cells under phase-contrast microscopy: control, mock or WT-BAG3-transfected FRO cells that were polyhedral and grew in a tightly connected manner, displayed an intermediate morphology between epithelial-like and fibroblast-like. S187A-BAG3 and S187D-BAG3 demonstrated opposite effects on morphological change of FRO cells: S187D-BAG3 cells exhibited a spindleshaped, more elongated morphology and became more loosely arranged, reminiscing some mesenchymal-like characteristics. On the other hand, S187A-BAG3 cells were cuboidal-shaped and organized in compact islets, reminiscing some epithelial-like characteristics. We further demonstrated that S187D-BAG3 induced some EMT markers, and enhanced motility and invasiveness of FRO cells.
RESULTS

Identification of BAG3 as a novel candidate of PKCd
To globally identify candidates of PKCd, Chinese hamster ovary (CHO) cells were transfected with mock (control), dominant negative PKCd (DN-PKCd) or constitutively activated PKCd (CA-PKCd). Phosphoproteins were enriched from the three lysates using a commercially available purification kit, and labeled with cyanine dyes Cy2 (mock), Cy3 (DN-PKCd) and Cy5 (CA-PKCd), respectively. Phosphoprotein-enriched fractions were combined and subjected to 2D-DIGE (Figure 1a-c) . The Cy2, Cy3 and Cy5 signals were individually scanned at mutually exclusive excitation/emission wavelengths, which exhibited as blue, green, and red pseudocolors, respectively (Figure 1a-c) . A merge of three images was showed in Supplementary Figure 1A and a magnified view of a boxed region in Supplementary Figure 1A was presented in Supplementary Figure 1B. There were a large amount of red spots, the amount of which was higher in CA-PKCd than in mock or DNPKCd-transfected cells (Supplementary Figures 1A and 1B) . As phosphoproteins were enriched before 2D-DIGE was performed, these red spots were potential candidates for proteins phosphorylated by PKCd.
The spots corresponding to those red spots in Supplementary Figure 1B were excised and subjected to peptide mass fingerprinting. MASCOT data base search algorithms demonstrated that spot 5 in Supplementary Figure 1B Promotion of EMT and invasion by BAG3 N Li et al CDCP1, SP1, PKCD, PDPK1, GSK3b, RACK1, 14-3-3z, 14-3-3g and HSP27 (Supplementary Table 1 ).
PKCd interacted with and phosphorylated BAG3 in vivo To confirm whether BAG3 might be a phosphorylated candidate by PKCd, we performed coimmunoprecipitation experiments, and found an interaction between Flag-tagged BAG3 and Myc-tagged PKCd in CHO cells (Figure 2a ). In addition, BAG3 interacted more strongly with CA-PKCd than WT-PKCd or DN-PKCd (Figure 2a) . We also detected an interaction between endogenous PKCd and BAG3 in several cell lines (Figure 2b ). The negative control using immunoglobulin G for the immunoprecipitation confirmed the specific interaction between PKCd and BAG3 (Supplementary Figure 2) . In addition, this interaction between PKCd and BAG3 was reduced in cells treated with 5 mM of rottlerin, a specific inhibitor of PKCd, whereas increased in cells treated with 10 ng/ml of phorbel 12-myristate 13-acetate (TPA), an activator of PKCd, in CHO cells (Figure 2c ). To examine whether PKCd can phosphorylate BAG3 in vivo, Flagtagged human BAG3-expressing cells were transfected with mock, WT-PKCd, CA-PKCd or DN-PKCd. These total lysates were used for second dimension immunoblot with anti-Flag antibody (Figure 2d BAG3 was directly phosphorylated by PKCd on Ser187 site To identify the phosphorylation site on BAG3, which is specifically phosphorylated by PKCd, we scanned the whole peptide sequences of BAG3, and noticed that there was one potential PKCd phosphorylation site, Ser 187, in the BAG3 protein, and that this site was highly conserved across species. We therefore constructed a vector expressing a human BAG3 fragment (1-347aa) in which Ser187 was replaced by Ala, which was a nonphosphorylatable substitution. An in vitro kinase assay demonstrated that PKCd phosphorylated WT-BAG3 fragment but not mutant BAG3 fragment in which Ser187 was replaced by Ala (S187A-BAG3) (Figure 3a) .
To confirm that the phosphorylation of BAG3 on Ser187 was the phosphorylation site in response to PKCd in vivo, 2D immunoblot was performed using CHO cells, coexpressing WT-BAG3 or S187A-BAG3 with CA-PKCd or DN-PKCd (Figure 3b ). Four spots representing Flag-tagged BAG3 with different pI values were detectable in CHO cells coexpressing WT-BAG3 and CA-PKCd, whereas only two forms of BAG3 with more basic pI values were observed in cells expressing S187A-BAG3 or WT-BAG3 with DNPKCd ( Figure 3b ). These results demonstrated that BAG3 was phosphorylated at Ser187 in response to PKCd activation in vivo.
Phosphorylation of BAG3 at S187 site caused morphological changes consistent with EMT in FRO cells To investigate potential function of phosphorylation of BAG3 at S187, we generated FRO subline cells stably expressing WT-BAG3, S187A-BAG3 or S187D-BAG3. Under phase contrast microscopy, we noticed untransfected or mock-transfected FRO cells were polyhedral and grew in tightly connected manner, WT-BAG3-transfected FRO subline cells demonstrated no obvious alteration in shape (Figure 4a ). However, S187D-BAG3 cells exhibited a spindle-shaped, more elongated morphology and became more loosely arranged (Figure 4a ). On the other hand, most of S187A-BAG3 cells were cuboidal-shaped and organized in compact islets (Figure 4b ). Exogenous overexpression of S187D-BAG3 resulted in a change to a cellular fibroblast-like morphology consistent with EMT; on the contrary, S187A-BAG3 overexpression led to a change to a cellular epithelial-like morphology ( Figure 4b ). Quantitative morphometric analysis showed that S187D-BAG3 cells demonstrated more elongated morphology, whereas S187A-BAG3 cells demonstrated more cuboidal shape (a) CHO cells were co-transfected with Flag-BAG3 and the indicted Myc-tagged PKCd, immunoprecipitated fractions with an antibody against Myc were subjected to western blot analysis using antibodies against Myc or Flag. Whole-cell lysate (input) was also subjected to western blot analysis to examine the expression of PKCd and BAG3. (b) Lysates from the indicated cells were immunoprecipitated with an antibody against BAG3, and western blot analyses were performed using antibodies against BAG3 or PKCd. (c) CHO cells were treated with TPA or rottlerin, and the interaction between endogenous BAG3 and PKCd was examined by immunoprecipitation and western blotting with antibodies against either BAG3 or PKCd. (d) CHO cells were co-transfected with the indicated plasmid and Flag-BAG3, 2D immunoblots were performed using an antibody against Flag.
Promotion of EMT and invasion by BAG3 N Li et al compared with control or WT-BAG3 cells (Figure 4c ). These data suggested that BAG3 might be implicated in regulation of EMT, and phosphorylation state at Ser187 site might have a critical role in its regulatory effects on EMT.
BAG3 and its phoshorylation state at Ser187 site resulted in the changes of EMT marker genes in FRO cells EMT is a transcriptional program that downregulates expression of epithelial genes and upregulates expression of mesenchymal genes. To investigate whether BAG3-induced changes in morphology were consistent with changes in expression of EMT marker genes, we performed real-time reverse transcriptase-PCR. Consistent with a mesenchymal-like morphological alteration, S187D-BAG3 cells demonstrated higher mesenchymal markers, N-cadherin and vimentin mRNA expression, and lower epithelial marker, E-cadherin mRNA expression levels, compared with parent or mock cells (Figure 5a ). S187A-BAG3 cells displayed lower N-cadherin and vimentin mRNA expression levels, whereas higher E-cadherin mRNA expression levels (Figure 5a ), which was also consistent with an epithelial-like morphological alteration. Although no obvious morphological alteration was observed, similar like S187A-BAG3 cells, WT-BAG3 cells also demonstrated lower N-cadherin and vimentin mRNA expression levels, higher E-cadherin mRNA expression levels, compared with parent or mock cells (Figure 5a ). It should be noted that WT-BAG3 demonstrated weaker effects on the mRNA expression of these EMT markers compared with S187A-BAG3 (Figure 5a ). Transient transfection of BAG3 or its variants demonstrated that similar transcriptional regulation of EMT markers was also observed in other thyroid cancer cells, including KTC1 (supplementary Figure 3A) and KTC3 (supplementary Figure 3B ) cells. Consistent with mRNA expression, western blot analysis demonstrated that E-cadherin proteins were increased, whereas N-cadherin and vimentin proteins were decreased in S187A-BAG3 cells (Figure 5b ). Western blot also confirmed that N-cadherin and vimentin was significantly increased in S187D-BAG3 cells (Figure 5b ). However, inconsistent with mRNA expression levels, there were no significant changes in the levels of E-cadherin in S187D-BAG3 cells (Figure 5b ). In WT-BAG3 cells, consistent with mRNA expression, E-cadherin protein was increased (Figure 5b) . However, contrary to reduction in mRNA levels, N-cadherin protein was significantly increased, while no obvious alteration of vimentin protein was observed in WT-BAG3 cells (Figure 5b ). Immunofluorescence (IF) assays also confirmed that S187A-BAG3 cells demonstrated weaker N-cadherin and vimentin IFs compared with FRO cells, whereas S187D-BAG3 cells displayed stronger IFs of N-cadherin and vimentin (Figure 5c ). E-cadherin IF assay demonstrated enhanced IF in WT-BAG3 and S187A-BAG3 cells (Figure 5c ). In addition, in FRO and S187A-BAG3 cells, E-cadherin was primarily located at the periphery of cells, while internalization of E-cadherin was observed in WT-BAG3 and S187D-BAG3 cells (Figure 5c ).
We further examine the distribution of another epithelial marker, b-catenin using IF assay. b-catenin was predominantly at the membrane in control FRO and S187A-BAG3 cells, while WT-BAG3 and S187D-BAG3 caused an increase and redistribution of b-catenin to the intracellular space (Figure 5d ). Furthermore, S187D-BAG3 cells demonstrated obvious perinuclear localization of b-catenin (Figure 5d ).
BAG3 and its phosphorylation state at Ser187-regulated migration and invasion of FRO cells As EMT involves increased mobility and an invasive phenotype, [25] [26] [27] in vitro migration and invasion assays, including would-healing and Transwell assays, were used to investigate the impact of BAG3 on invasive potency of thyroid cancer FRO cells. Data of the would-healing assay indicated that motivity of FRO cells was increased by WT-BAG3 overexpression, and S187D-BAG3 further enhanced the promotion of motion induced by WT-BAG3 (Figure 6a ). Transwell migration assays also supported that WT-BAG3 and S187D-BAG3 significantly promoted the migration of FRO cells, and S187D-BAG3 demonstrated more potent promotion effects than WT-BAG3 (Figure 6b and supplementary Figure 4A ). To investigate the effect of BAG3 on invasiveness, cells were seeded onto Matrigel basement membrane matrix-coated filters, and results showed that both WT-BAG3 and S187D-BAG3 significantly increased the invasive potential of FRO cells (Figure 6c and supplementary Figure 4B) .
To confirm the role of BAG3 phosphorylation mediated by PKCd in cell invasiveness, WT-BAG3 cells were treated with TPA and rottlerin to activate and suppress PKC signaling, respectively. Matrix-coated Transwell invasion assay demonstrated that TPA significantly increased, whereas rottlerin significantly decreased invasive potential of WT-BAG3 cells (Figure 6d ). In vitro kinase assay was performed using GST-BAG3 N-terminal fragment (WT-BAG3) or GST-BAG3 N-terminal fragment with mutation at Ser187 to alanine (S187A-BAG3) as a substrate, and PKCd as a kinase. Phosphorylated products were subjected to autoradiography and CBB staining was presented under the image. (b) CHO cells were transfected with the indicated plasmids, and 2D immunoblots were performed using an antibody against Flag.
DISCUSSION
Promotion of EMT and invasion by BAG3 N Li et al pathogenesis of numerous disorders. In this study, we globally identified potential substrates of PKCd by combining phosphoprotein enrichment, 2D-DIGE and mass spectrometry, and detected that BAG3 was one of the candidates of PKCd cascade. We detected that PKCd interacted with BAG3 in several cell types, and identified that PKCd phosphorylated BAG3 on Ser187 site in vivo. BAG3, also known as Bis or CAIR-1, belongs to the evolutionarily conserved BAG family of proteins that are considered to function as molecular chaperone regulators. 28 BAG3 binds with the ATPase domain of Hsc70 with a high affinity and suppresses its chaperone activity. 9,29 BAG3 has been reported to possess prosurvival activity by enhancing Bcl-2 activity. 8 In support of this, BAG3 has been reported to be upregulated in several tumors, [11] [12] [13] [14] [15] [16] and it is thought that BAG3 has a prosurvival role in some types of leukemia. 13, 14 Furthermore, it has been reported that as an adapt response, BAG3 expression is induced by some stressful stimuli such as high temperatures, heavy metals, proteasome inhibition and virus infections. 19, 30, 31 Recently, a novel role has been Representative data shown are from a single experiment, for which n was at least 50 for each cell type. Similar data was obtained from three independent cell preparations. * indicates Po0.01.
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ascribed to BAG3 in regulating macroautophagy. [32] [33] [34] With respect to cancer, BAG3 is also reported to be implicated in modulation of adhesion, motility and invasiveness of epithelial cancer cells. 16, 20, 21 Studies of BAG3 on different cell types, however, have resulted in conflicting results on whether it is associated with increased or decreased motility. 16, 20, 21 Iwasaki et al. 20 reported that BAG3 localized to the leading edge of migrating cells, regulated the actin À cytoskeleton and increased cell motility and invasion in Cos7, MCF7, Du145 and ALVA31 cells. Similarly, studies on ovarian cancers demonstrated that BAG3 bound with matrix metalloproteinase (MMP)-2 positively regulated motility and aggressiveness of ovarian cancer cells. 16 Paradoxically, Kassis et al. 21 found that decreased invasiveness in WT-BAG3-overexpressing MDA435 cells, and increased adhesion and migration in deletion of PXXP-domain BAG3-overexpressing cells. The current study demonstrated that WT-BAG3 augmented motility and invasion of FRO cells, and S187D-BAG3 exerted further potent effects on promoting motility and invasiveness of FRO cells. In the case of S187A-BAG3, although without statistical difference, it demonstrated a tendency to suppress motion and invasion of FRO cells. As the migratory and invasive potential of FRO cells per se were very low, the difference might be comprised. Thus, we speculate that the difference in the phenotype observed for BAG3 overexpression in different cancer cells may be, at least in part, ascribed to differences in the status of BAG3 phosphorylation on Ser187 site. Generation a specific antibody recognized Ser187 phosphorylated form of BAG3 in the future might clarify this issue.
EMT is the process by which adherent epithelial cells convert to motile mesenchymal cells, and is essential in embryonic Recently, it has become increasingly clear that EMT also occurs in a variety of tumors, and has important roles in the progression of cancer, and is also responsible for the resistant phenotype of cancer cells to conventional chemotherapeutics. 35 This process is a transcriptional program that downregulates expression of epithelial genes and upregulates expression of mesenchymal genes, resulting in a loss of epithelial cell polarity and acquisition of a fibroblastoid phenotype, thereby enabling tumor cells to leave epithelial cell organization. 36 Under phase contrast microscopy, we found marked morphological alterations in S187A-BAG3-or S187D-BAG3-overexpressing FRO cells, indicating that BAG3 and its phosphorylation state at Ser187 might be implicated in modulation of EMT process. Real-time PCR, western blot analysis and IF confirmed that BAG3 changed expression of EMT markers, E-cadherin, N-cadherin and vimentin, S187A-BAG3 upregulated epithelial marker E-cadherin and downregulated mesenchymal markers N-cadherin and vimentin; on the contrary, S187D-BAG3 increased mesenchymal markers, N-cadherin and vimentin. In the case of WT-BAG3, mRNA levels of EMT markers were not consistent with their protein levels, the mechanism remains to be clarified. As BAG3 is implicated in regulation of autophagy and proteasomal activity, 37,38 two conserved intracellular proteolysis systems, which are critical to maintain intracellular protein homeostasis, WT-BAG3 might influence degradation of EMT marker proteins, resulting in discrepancy between mRNA and protein expression levels.
b-catenin is a cytoplasmic plaque protein that has a dual role in EMT: on one hand, it links E-cadherin to the cytoskeleton to suppress EMT, and on the other hand, it serves as a cotranscriptional activator together with T-cell factor/LEF, and the b-catenin/ T-cell factor/LEF complex directly controls gene expression positively associated with EMT. 39 Although b-catenin is localized to cell membranes in normal epithelial cells and noninvasive tumor cells, it is located either in the cytoplasm or in the nucleus in cells that undergo EMT. 40, 41 In the current study, we found that WT-BAG3 and S187D-BAG3 significantly increased internalization of b-catenin. Further investigation is required to clarify whether internalization of b-catenin by BAG3 affects its transcriptional activity.
During EMT procedure, epithelial cells acquire an invasive, mesenchymal phenotype, which has been generally postulated to increase migratory and invasive capabilities. 22 In the current study, WT-BAG3 enhanced the expression of epithelial marker and decreased the expression of mesenchymal markers. However, WT-BAG3 cells migrated and invaded faster than FRO cells, indicating that besides EMT modulation, other mechanisms might also be ascribed to regulatory effects of BAG3 on motion and migration of FRO cells.
In summary, our study showed that PKCd associated with and phosphorylated BAG3 on Ser187. We also demonstrate a role of phosphorylated BAG3 at Ser187-induced EMT and enhanced invasiveness of thyroid cancer cells.
MATERIALS AND METHODS
Identification of candidate substrates of PKCd
A complementary DNA (cDNA) encoding human WT-PKCd was generated by PCR from human brain cDNA library (Invitrogen, Carlsbad, CA, USA) and subcloned into the BamHI and EcoRI sites of pcDNA3.1-Myc. Its DN-PKCd mutant, K376R, and CA-PKCd mutant, R144/145A, 42 constructs were generated by a PCR-based method. CHO cells were transfected with mock, DN-PKCd or CA-PKCd, and total cell lysates were prepared from these cells. To enrich phosphorylated proteins, each extract was subjected to a phosphoprotein purification kit (Qiagen, Hilden, Germany), and Promotion of EMT and invasion by BAG3 N Li et al protein concentration was determined using BCA kit (Amersham Biosciences, Buckinghamshire, UK). According to the manufacturer's instructions, three purified samples (100 mg each) from mock, DN-PKCdor CA-PKCd-transfected cells were labeled with Cy2, Cy3 and Cy5 minimal dyes (Amersham Biosciences), respectively. Labeled samples were combined and passively rehydrated into a 24-cm pH4-7 immobilized pH gradient strips (Amersham Biosciences) for 12 h, and subjected to isoelectric focusing using the Ettan IPGphor isoelectric focusing system (Amersham Biosciences) for a total of 61 500 V-h (hold at 500 V for 500 V-h, hold at 1 kV for 1 kV-h and hold at 8 kV for 60 kV-h). Reduction and carbamidomethylation of cysteine sulfhydryls were performed according to the manufacturer's instruction. The second-dimension SDS-polyacrylamide gel electrophoresis was carried out with Ettan DALT twelve (Amersham Biosciences). The Cy2, Cy3 and Cy5 signals were individually imaged with mutually exclusive excitation/emission wavelengths of 480/530, 520/590 and 620/680 nm, respectively, using Typhoon 9400 (Amersham Biosciences). Pairwise comparisons of Cy2 and Cy3, Cy2 and Cy5, or Cy3 and Cy5 images, and quantitative determination of intensity changes of all spots among three combinations were performed using Decyder software (Amersham Biosciences).
Determination of proteins of interest using 2D-DIGE and mass spectrometry
Phosphoprotein-enriched sample prepared as above from CA-PKCdtransfected CHO cells (800 mg, nonlabeled) was subjected to second dimension gel, transferred to ProBlott membranes (Applied Biosystems, Foster City, CA, USA) and stained with Coomassie Brilliant Blue. Proteins of interest were excised, equilibrated with a reduction buffer (0.5 M Tris, pH 8.5, 8 M guanidine hydrochloride, 0.3% EDTA, 5% acetonitrile) and digested with 1 pmol of lysylendopeptidase (Wako, Saitama, Japan) in 6 ml of digestion buffer (18 mM Tris, pH 8.9, 70% acetonitrile) for 90 min at 37 1C.
Acetonitrile was added to a final concentration of 90%, and the sample was desalted and concentrated using ZipTip HPL (Millipore Corp., Bedford, MA, USA). Peptides were eluted with 1 ml of matrix solution (0.1% acetic acid, 50% acetonitrile, saturated with a-cyano-4-hydroxycinnamic acid), and applied onto a sample plate (Applied Biosystems). Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was performed using a Voyager-DE PRO (PerSeptive Biosystems, Framingham, MA, USA). Ions specific for each sample were then used to interrogate human protein sequences in the NCBInr database using the MASCOT (available on the World Wide Web at www.matrixscience.com) database search algorithms.
In vitro PKCd assays
Phosphorylation of recombinant GST-BAG3 or GST-BAG3-S187A fragment by PKCd was examined by incubation of 500 ng of active-PKCd (Upstate Biotechnology Inc., Lake Placid, NY, USA) with 1.0 mg each of GST-BAG3 or GST-BAG3-S187A and 5 m Ci of [g-32 P]-ATP (Amersham Biosciences) in 20 ml of a kinase buffer (20 mM Tris, pH 7.5, 10 mM MgCl 2 , 0.1 mM ATP) for 30 min at 30 1C. Reactions were terminated with Laemmli SDS sample buffer to a final volume of 30 ml, halves of the samples were subjected to 10% SDSpolyacrylamide gel electrophoresis; Coomassie-stained and phosphorylation reactions were visualized by autoradiography.
2D western blotting
Proteins were rehydrated into pH 3 À 10 NL immobilized pH gradient ZOOM strips followed by isoelectric focusing using ZOOM IPGRunner System (Invitrogen, Life Technologies). Second dimension SDS-polyacrylamide gel electrophoresis was performed on NuPAGE Novex 4-12% Bis-Tris ZOOM Gel with XCell SureLock Mini-Cell (Invitrogen, Life Technologies), using standard conditions.
DNA constructs and generation of stable cell lines
A cDNA encoding human BAG3 was generated by PCR from human brain cDNA library (Invitrogen) and subcloned into the eukaryotic expression plasmid, pcDNA3, tagged with enhanced green fluorescent protein (EGFP) to generate WT-BAG3 construct. S187A-BAG3 and S187D-BAG3 were constructed in which Ser187 was replaced by Ala (Ser187A) or Asp (Ser187D) from WT-BAG3 by a PCR-based method. FRO cells were transfected with various BAG3 construct using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction, and stable clonal cell lines were selected with 1 mg/ml G418 and were maintained at 0.2 mg/ ml G418.
Western blot analysis
Cells were lysed in lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100 and protease inhibitor cocktail) (Sigma-Aldrich, St Louis, MO, USA). Cell extract protein amounts were quantified using the bovine serum albumin protein assay kit. Equivalent amounts of protein (25 mg) were separated using 12% SDS-polyacrylamide gel electrophoresis, and transferred to polyvinylidene fluoride membrane (Millipore Corporation, Billerica, MA, USA).
Quantification of elongated cell morphology
Elongated cell morphology was measured as previously reported. 43 Briefly, cells were stained for F-actin with rhodamine-labeled phalloidin and nuclei with DAPI, and images of cells were acquired using a Â 40 objective. The lengths of the major and minor cell axes were measured using DP2-BSW software (Olympus, Tokyo, Japan). The ratios of the major to minor axis of cells were used to determine the degree of elongated cell morphology. For each experiment, at least 50 cells were measured.
IF staining and fluorescence microscopy Cells were fixed with 4% paraformaldehyde, permeabilized for 5 min with phosphate-buffered saline containing 0.1% Triton X-100 and blocked with 1% bovine serum albumin. Immunostaining was performed using the appropriate primary and secondary antibodies, and images were acquired using an Olympus fluorescence microscope.
Scratch wound-healing assay
Cells were seeded in a six-well plate and grown overnight to confluence. The monolayer cells were scratched with a sterile pipette tip to create a wound, and cells were washed twice with serum-free DMEM to remove floating cells, and then replaced with medium without serum. The cells migrating from the leading edge were photographed at 0 and 24 h. Multiple views of each well were documented, and three independent experiments were performed.
Transwell migration and invasion assays
In vitro Transwell migration assays were performed in modified Boyden chambers with 8 mm pore filter inserts in 24-well plates (BD Biosciences, San Jose, CA, USA). Briefly, the lower chamber was filled with DMEM containing 10% fetal bovine serum. Cells were collected after trypsinization, re-suspended in 200 ml of DMEM medium and transferred to the upper chamber (1 Â 10 5 cells/well). After 24 h of incubation, the filter was gently removed from the chamber, and the cells on the upper surface were removed using a cotton swab. Cells were fixed and nuclei were stained with DAPI. Cells were counted in five representative microscopic fields and photographed. Three independent experiments were performed.
The invasion assay was performed using BD BioCoat Matrigel invasion chambers (BD Biosciences; 8 mm pore size). The same procedures described above were used, except the filters were pre-coated with 100 ml Matrigel at a 1:4 dilution in DMEM to form a genuine reconstituted basement membrane.
Statistics
The statistical significance of the difference was analyzed by analysis of variance (ANOVA) and post hoc Dunnett's test. Statistical significance was defined as Po0.05. All experiments were repeated three times, and data were expressed as the mean ± s.d. from a representative experiment.
